Compare Enveric Biosciences Inc (ENVB) vs Franklin FTSE South Korea ETF (FLKR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Franklin FTSE South Korea ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.80M), while Franklin FTSE South Korea ETF trades at $58.26 (market cap $1.83B). The key difference: Franklin FTSE South Korea ETF is far larger — about 269.1× Enveric Biosciences Inc's market cap, and Franklin FTSE South Korea ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Franklin FTSE South Korea ETF for 15 Days on average.
| ENVB | FLKR | |
|---|---|---|
Market Cap | $6.80M | $1.83B |
Volume | 64,867 | 679,902 |
Sector | Health | Broad Market / Factor |
52-Week High | $10.80 | $72.25 |
52-Week Low | $1.27 | $27.09 |
Typical Hold Time | 14 Days | 15 Days |
Enterprise Value | -$1.49M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →
